ILC3s control splenic cDC homeostasis via lymphotoxin signaling - Institut Pasteur Access content directly
Journal Articles Journal of Experimental Medicine Year : 2021

ILC3s control splenic cDC homeostasis via lymphotoxin signaling

James P. Di Santo

Abstract

The spleen contains a myriad of conventional dendritic cell (cDC) subsets that protect against systemic pathogen dissemination by bridging antigen detection to the induction of adaptive immunity. How cDC subsets differentiate in the splenic environment is poorly understood. Here, we report that LTα 1 β 2-expressing Rorgt + ILC3s, together with B cells, control the splenic cDC niche size and the terminal differentiation of Sirpα + CD4 + Esam + cDC2s, independently of the microbiota and of bone marrow pre-cDC output. Whereas the size of the splenic cDC niche depended on lymphotoxin signaling only during a restricted time frame, the homeostasis of Sirpα + CD4 + Esam + cDC2s required continuous lymphotoxin input. This latter property made Sirpα + CD4 + Esam + cDC2s uniquely susceptible to pharmacological interventions with LTβR agonists and antagonists and to ILC reconstitution strategies. Together, our findings demonstrate that LTα 1 β 2-expressing Rorgt + ILC3s drive splenic cDC differentiation and highlight the critical role of ILC3s as perpetual regulators of lymphoid tissue homeostasis.

Domains

Immunology
Fichier principal
Vignette du fichier
jem_20190835.pdf (6.36 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03258252 , version 1 (11-06-2021)

Licence

Attribution - NonCommercial - ShareAlike

Identifiers

Cite

Matthias Vanderkerken, Antonio P. Baptista, Marco de Giovanni, Satoshi Fukuyama, Robin Browaeys, et al.. ILC3s control splenic cDC homeostasis via lymphotoxin signaling. Journal of Experimental Medicine, 2021, 218 (5), pp.e20190835. ⟨10.1084/jem.20190835⟩. ⟨pasteur-03258252⟩
65 View
79 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More